Jenny G. Low

1. SARS-CoV-2 breakthrough infection in vaccinees induces virus-specific nasal-resident CD8+ and CD4+ T cells of broad specificity
   2022/08/04 by Joey Ming Er Lim, Anthony Tanoto Tan, Anthony T. Tan +5 · 27 citations
   Immunology and Microbiology · Medicine · #2019-20 coronavirus outbreak #Biology #CD8 #COVID-19 Clinical Research Studies #Coronavirus disease 2019 (COVID-19) #Immune responses and vaccinations #Immune system #Immunology #Infectious disease (medical specialty) #Medicine #Outbreak #Pathology #SARS-CoV-2 and COVID-19 Research #Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) #Virology #Virus
2. Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore
   2020/03/03 by Barnaby Edward Young, Sean Wei Xiang Ong, Shirin Kalimuddin +24 · 3 citations
   Medicine · #COVID-19 Clinical Research Studies #SARS-CoV-2 detection and testing #SARS-CoV-2 and COVID-19 Research
3. Safety and immunogenicity of a single dose of a tetravalent dengue vaccine with two different serotype-2 potencies in adults in Singapore: A phase 2, double-blind, randomised, controlled trial
   2019/12/13 by Vianney Tricou, Jenny G. Low, Helen Oh +13 · 22 citations
   Biochemistry, Genetics and Molecular Biology · Medicine · #Antibody #Biological Research and Disease Studies #Dengue fever #Dengue vaccine #Dengue virus #Immunogenicity #Immunology #Internal medicine #Medicine #Mosquito-borne diseases and control #Randomized controlled trial #Serostatus #Viral Infections and Outbreaks Research #Viral load